Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » BioDiem- OPAL Update and EOFY Information

BioDiem- OPAL Update and EOFY Information July 10, 2017 • Category • Author Name

BioDiem_OPAL Update and EOFY information

Latest News

CEO AGM 2023 Presentation

November 30, 2023

View the CEO AGM 2023 Presentation

Read More
BioDiem Results of Annual General Meeting

November 30, 2023

To view the BioDiem Results of Annual General Meeting read the PDF here

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions